Home › Asset managers › Compare 2025-2026 › American Century vs Charles Schwab
American Century 2025-2026 · Charles Schwab 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,033 | 12,345 | 1,588 | 100 | 88.6% | 88.3% |
| Board proposals | 13,138 | 11,577 | 1,486 | 75 | 88.6% | 88.4% |
| E&S shareholder proposals | 154 | 148 | 6 | 0 | 96.1% | 96.1% |
| Other items | 741 | 620 | 96 | 25 | 86.6% | 85.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,561 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Charles Schwab |
|---|---|---|---|---|---|---|
| KILROY REALTY CORPORATION | May 19, 2026 | Approval of the amendment and restatement of the Company's 2006 Incentive Award Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 11 funds |
| KINDERCARE LEARNING COMPANIES, INC. | June 4, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| KINDERCARE LEARNING COMPANIES, INC. | June 4, 2026 | Election of one Class I director nominee to serve until the 2028 annual meeting of stockholders Jean Desravines Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 3 funds |
| KINGSTONE COMPANIES, INC. | August 6, 2025 | To approve, on a non-binding advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| KINGSWAY FINANCIAL SERVICES INC. | May 18, 2026 | To approve an amendment to the Corporation's 2020 Equity Incentive Plan dated September 21, 2020 to increase the number of Common Shares reserved for issuance; and Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| KINIKSA PHARMACEUTICAL INTERNATIONAL PLC | May 29, 2026 | To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| KINIKSA PHARMACEUTICAL INTERNATIONAL PLC | May 29, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| KIRBY CORPORATION | April 27, 2026 | Approval of Amendment of the 2005 Stock and Incentive Plan Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| KLAVIYO, INC. | June 9, 2026 | To approve, on a non-binding advisory basis, the compensation of Klaviyo's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| KODIAK GAS SERVICES, INC. | May 7, 2026 | Advisory, non-binding vote to approve the compensation of Kodiak Gas Services, Inc.'s named executive officers for 2025; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| KODIAK SCIENCES INC. | June 2, 2026 | Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| KRATOS DEFENSE & SEC SOLUTIONS, INC. | May 12, 2026 | To approve an amendment and restatement of our 2023 Equity Incentive Plan to increase the number of shares of common stock issuable under such plan by 6,900,000 shares. Compensation |
Board | For | AGAINST 5 funds |
FOR 11 funds |
| KRONOS WORLDWIDE, INC. | May 13, 2026 | Election of Directors: Cecil H. Moore, Jr. Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 3 funds |
| KRONOS WORLDWIDE, INC. | May 13, 2026 | Election of Directors: Michael S. Simmons Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 3 funds |
| KRYSTAL BIOTECH, INC. | May 15, 2026 | Approval of the Company's Non-Employee Director Compensation Policy. Compensation |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| KRYSTAL BIOTECH, INC. | May 15, 2026 | Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| KULICKE AND SOFFA INDUSTRIES, INC. | March 4, 2026 | To approve, on a non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 7 funds |
| KURA ONCOLOGY, INC. | June 4, 2026 | Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| KURA ONCOLOGY, INC. | June 4, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| KYMERA THERAPEUTICS, INC. | June 24, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers; and Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| LA-Z-BOY INCORPORATED | August 26, 2025 | To approve, through a non-binding advisory vote, the compensation of the company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| LAKELAND FINANCIAL CORPORATION | April 14, 2026 | APPROVAL, by non-binding vote, of the Company's compensation of certain executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 9 funds |
| LAKELAND INDUSTRIES, INC. | June 16, 2026 | Approve the Lakeland Industries, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| LAMAR ADVERTISING COMPANY | May 14, 2026 | Approval of an amendment and restatement of the Company's 1996 Equity Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 16 funds |
| LAMAR ADVERTISING COMPANY | May 14, 2026 | Approval of an amendment and restatement of the Company's 2019 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 16 funds |
| LARIMAR THERAPEUTICS, INC. | May 19, 2026 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| LATTICE SEMICONDUCTOR CORPORATION | May 1, 2026 | To approve on a non-binding, advisory basis, our Named Executive Officer's compensation. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 14 funds |
| LAUREATE EDUCATION, INC. | May 21, 2026 | To approve the Laureate Education, Inc. 2026 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| LAZARD INC. | May 21, 2026 | Non-binding advisory vote regarding executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 11 funds |
| LCI INDUSTRIES | May 12, 2026 | To approve the LCI Industries Amended 2018 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| LEGENCE CORP | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| LEMONADE, INC. | June 3, 2026 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| LENDINGCLUB CORPORATION | June 2, 2026 | Approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| LENDINGTREE INC | June 17, 2026 | Advisory vote to approve LendingTree, Inc.'s executive compensation (say-on-pay). Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| LENNAR CORPORATION | April 8, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 14 funds |
| LENSAR INC | July 2, 2025 | To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to LENSAR's named executive officers that is based on or otherwise relates to the Merger; and Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| LIBERTY GLOBAL LTD | June 23, 2026 | To approve, on an advisory basis, the compensation of our named executive officers as described in this proxy statement under the heading ''Executive Officer and Director Compensation;'' and Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 1 fund |
| LIBERTY LIVE HOLDINGS, INC. | May 11, 2026 | The say-on-pay proposal, to approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| LIFE TIME GROUP HOLDINGS, INC. | April 22, 2026 | To approve, by a non-binding vote, the named executive officer compensation as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 9 funds |
| LIFE360, INC. | May 28, 2026 | An advisory, non-binding vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| LIFECORE BIOMEDICAL, INC | October 29, 2025 | To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| LIFECORE BIOMEDICAL, INC. | June 4, 2026 | To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| LIFECORE BIOMEDICAL, INC. | June 4, 2026 | To approve the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| LIFEVANTAGE CORPORATION | November 6, 2025 | To approve a non-binding, advisory resolution approving the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| LIFEVANTAGE CORPORATION | November 6, 2025 | To approve an amendment to the 2017 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| LIGAND PHARMACEUTICALS INCORPORATED | June 5, 2026 | Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| LINCOLN NATIONAL CORPORATION | May 28, 2026 | The approval of an advisory resolution on the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 13 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Emily Fine Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Gordon Crawford Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Harry E. Sloan Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: John D. Harkey Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Jon Feltheimer Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Mark H. Rachesky Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Richard Rosenblatt Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Susan McCaw Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Yvette Ostolaza Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 9 funds |
| LIQUIDITY SERVICES, INC. | February 26, 2026 | Approval of an advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| LIVERAMP HOLDINGS, INC. | August 12, 2025 | Advisory (non-binding) vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| LIVERAMP HOLDINGS, INC. | August 12, 2025 | Approval of an increase in the number of shares available for issuance under the Company's Amended and Restated 2005 Equity Compensation Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| LOANDEPOT, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of loanDepot's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| LOUISIANA-PACIFIC CORPORATION | May 1, 2026 | Advisory vote to approve named executive officer compensation Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 13 funds |
| LSI INDUSTRIES INC. | November 4, 2025 | Advisory vote on the compensation of the named executive officers as described in the Company's proxy statement (the "Say-on-Pay vote"). Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| LUCID GROUP, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation for our named executive officers as disclosed in our Proxy Statement Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| LULULEMON ATHLETICA INC. | June 25, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | Contested | AGAINST 13 funds |
FOR 14 funds |
| LULULEMON ATHLETICA INC. | June 25, 2026 | Approval of an amendment to the 2023 Equity Incentive Plan to increase the share reserve. Compensation |
Board | Contested | AGAINST 12 funds |
FOR 13 funds |
| LUMENTUM HOLDINGS INC. | November 19, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 14 funds |
| LYFT, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of our named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 10 funds |
| Lakeland Financial Corporation | April 14, 2026 | ELECTION OF DIRECTORS: A. Faraz Abbasi Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 8 funds |
| Lakeland Financial Corporation | April 14, 2026 | ELECTION OF DIRECTORS: Bradley J. Toothaker Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 8 funds |
| Larimar Therapeutics, Inc. | May 19, 2026 | Election of Class III Directors for a Three-Year Term Expiring in 2029: Carole S. Ben-Maimon, M.D. Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 2 funds |
| Larimar Therapeutics, Inc. | May 19, 2026 | Election of Class III Directors for a Three-Year Term Expiring in 2029: Frank Thomas Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 2 funds |
| Larimar Therapeutics, Inc. | May 19, 2026 | Election of Class III Directors for a Three-Year Term Expiring in 2029: Joseph Truitt Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 2 funds |
| Legacy Housing Corporation | December 18, 2025 | Election of Directors: Curtis D. Hodgson Director Elections |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| Legacy Housing Corporation | December 18, 2025 | Election of Directors: Skyler M. Howton Director Elections |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| Linde Plc | July 29, 2025 | Election of Directors: Dr. Victoria Ossadnik Director Elections |
Board | For | FOR 12 funds |
AGAINST 13 funds |
| Loews Corporation | May 12, 2026 | Election of Directors: Dino E. Robusto Director Elections |
Board | For | FOR 8 funds |
AGAINST 14 funds |
| Lumentum Holdings Inc. | November 19, 2025 | Election of Directors: Julia S. Johnson Director Elections |
Board | For | FOR 1 fund |
AGAINST 12 funds |
| Lyell Immunopharma, Inc. | June 10, 2026 | Election of Class II Directors: Otis Brawley, M.D. Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 3 funds |
| M-TRON INDUSTRIES, INC. | June 16, 2026 | To approve a non-binding advisory resolution regarding the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| M-TRON INDUSTRIES, INC. | June 16, 2026 | To approve the Second Amended and Restated M-tron Industries, Inc. 2022 Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| MACROGENICS, INC. | May 19, 2026 | To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| MACROGENICS, INC. | May 19, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| MADISON SQUARE GARDEN ENTERTAINMENT CORP | December 10, 2025 | Approval of, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 6 funds |
| MAGNITE, INC. | June 8, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 5 funds |
| MAINSTREET BANCSHARES, INC. | May 21, 2026 | To vote, on an advisory, non-binding basis, to approve the compensation of the named executive officers. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| MANHATTAN ASSOCIATES, INC. | May 14, 2026 | Approval of the First Amendment to Manhattan Associates, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| MANPOWERGROUP INC. | May 8, 2026 | Approval of the amendment and restatement of the Equity Incentive Plan of ManpowerGroup Inc. Compensation |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| MAPLEBEAR INC. | May 22, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 13 funds |
FOR 13 funds |
| MAPLEBEAR INC. | May 22, 2026 | To elect the following Class III director nominees: Lily Sarafan Director Elections |
Board | For | WITHHOLD 12 funds |
FOR 12 funds |
| MARA HOLDINGS, INC. | June 18, 2026 | A non-binding, advisory vote on the compensation of our Named Executive Officers ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 6 funds |
| MARA HOLDINGS, INC. | June 18, 2026 | Approval of an amendment to our Amended and Restated 2018 Equity Incentive Plan (the "2018 Plan") to increase the number of shares of our common stock reserved under the 2018 Plan by 18 million shares. Compensation |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | May 26, 2026 | To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| MARINE PRODUCTS CORPORATION | May 12, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of Marine Products in connection with the transactions contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| MARKETWISE, INC. | June 4, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| MARVELL TECHNOLOGY, INC. | June 25, 2026 | An advisory (non-binding) vote to approve compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 12 funds |
| MASIMO CORPORATION | May 1, 2026 | To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 13 funds |
| MASTERCRAFT BOAT HOLDINGS INC | October 28, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| MATRIX SERVICE COMPANY | November 4, 2025 | Advisory vote on named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| MATRIX SERVICE COMPANY | November 4, 2025 | To approve a proposal to amend the Company's 2020 Stock and Incentive Compensation Plan to increase the number of shares of Common Stock of the Company authorized for issuance thereunder from 3,975,000 to 5,000,000. Compensation |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| MATTHEWS INTERNATIONAL CORPORATION | February 19, 2026 | To approve the adoption of the Second Amended and Restated 2019 Director Fee Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 7 funds |
← Previous Page 8 of 16 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.